[1]
Cornejo-Juárez, P.; Vilar-Compte, D.; García-Horton, A.; López-Velázquez, M.; Ñamendys-Silva, S.; Volkow-Fernández, P. Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients. BMC Infect. Dis., 2016, 16(1), 274.
[2]
Vitrat, V.; Hautefeuille, S.; Janssen, C.; Bougon, D.; Sirodot, M.; Pagani, L. Optimizing antimicrobial therapy in critically ill patients. Infect. Drug Resist., 2014, 7, 261-271.
[3]
Mirabile, A.; Vismara, C.; Crippa, F.; Bossi, P.; Locati, L.; Bergamini, C.; Granata, R.; Resteghini, C.; Conte, E.; Morelli, D.; Scarpellini, P.; Licitra, L. Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy. Head Neck, 2016, 38(S1), E1009-E1013.
[4]
Montassier, E.; Batard, E.; Gastinne, T.; Potel, G.; de La Cochetière, M.F. Recent changes in bacteremia in patients with cancer: A systematic review of epidemiology and antibiotic resistance. Eur. J. Clin. Microbiol. Infect. Dis., 2013, 32(7), 841-850.
[5]
Freifeld, A.G.; Bow, E.J.; Sepkowitz, K.A.; Boeckh, M.J.; Ito, J.I.; Mullen, C.A.; Raad, I.I.; Roldton, K.V.; Young, J.H.; Wingard, J.R. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin. Infect. Dis., 2011, 52(4), e56-e93.
[6]
Ramphal, R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin. Infect. Dis., 2004, 39(S1), S25-S31.
[7]
Wisplinghoff, H.; Seifert, H.; Wenzel, R.P.; Edmond, M.B. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin. Infect. Dis., 2003, 36(9), 1103-1110.
[8]
Hagiya, H.; Ohnishi, K.; Maki, M.; Watanabe, N.; Murase, T. Clinical characteristics of Ochrobactrum anthropi bacteremia. J. Clin. Microbiol., 2013, 51(4), 1330-1333.
[9]
European Centre for Disease Prevention and Control. Surveillance
of healthcare-associated infections and prevention indicators in European
intensive care units.Stockholm: ECDC,; , 2017.
[10]
Kanjee, R.; Koreishi, A.F.; Tanna, A.P.; Goldstein, D.A. Chronic postoperative endophthalmitis after cataract surgery secondary to vancomycin-resistant Ochrobactrum anthropi: Case report and literature review. J. Ophthalmic Inflamm. Infect., 2016, 6(1), 25.
[11]
Gomez, M.R.; Esteban, A.P.; Daza, J.S.; Nieto, J.S.; Alvarez, D.; Garcia, P.P. Prosthetic mitral valve endocarditis due to Ochrobactrum anthropi: Case report. J. Clin. Microbiol., 2004, 42(7), 3371-3373.
[12]
Appelbaum, P.C.; Campbell, D.B. Pancreatic abscess associated with Achromobacter group Vd biovar 1. J. Clin. Microbiol., 1980, 12(2), 282-283.
[13]
Jelveh, N.; Cunha, B.A. Ochrobactrum anthropi bacteremia. Heart Lung, 1999, 28(2), 145-146.
[14]
Pomara, C.; Riezzo, I.; Bello, S.; De Carlo, D.; Neri, M.; Turillazzi, E. A pathophysiological insight into sepsis and its correlation with postmortem diagnosis. Mediators Inflamm., 2016, 20164062829
[15]
Kern, W.V.; Oethinger, M.; Marre, R.; Kaufhold, A.; Rozdzinski, E. Ochrobactrum anthropi bacteremia: Report of four cases and short review. Infection, 1993, 21(5), 306-310.
[16]
Nadjar, D.; Labia, R.; Cerceau, C.; Bizet, C.; Philippon, A.; Arlet, G. Molecular characterization of chromosomal class C beta-lactamase and its regulatory gene in Ochrobactrum anthropi. Antimicrob. Agents Chemother., 2001, 45(8), 2324-2330.
[17]
Deliere, E.; Vu-Thien, H.; Levy, V.; Barquins, S.; Schlegel, L.; Bouvet, A. Epidemiological investigation of Ochrobactrum anthropi strains isolated from a haematology unit. J. Hosp. Infect., 2000, 44(3), 173-178.
[18]
Holmes, B.; Popoff, M.; Kiredjian, M.; Kersters, K. Ochrobactrum anthropi gen. nov., sp. nov. from human clinical specimens and previously known as group Vd. Int. J. Syst. Bacteriol., 1988, 38(4), 406-416.
[19]
Earhart, K.C.; Boyce, K.; Bone, W.D.; Wallace, M.R. Ochrobactrum anthropi infection of retained pacemaker leads. Clin. Infect. Dis., 1997, 24, 281-282.
[20]
Naik, C.; Kulkarni, H.; Darabi, A.; Bhanot, N. Ochrobactrum anthropi: A rare cause of pneumonia. J. Infect. Chemother., 2013, 19(1), 162-165.
[21]
Quirino, A.; Pulcrano, G.; Rametti, L.; Puccio, R.; Marascio, N.; Catania, M.R.; Matera, G.; Liberto, M.C.; Focà, A. Typing of Ochrobactrum anthropi clinical isolates using automated repetitive extragenic palindromic-polymerase chain reaction DNA fingerprinting and matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry. BMC Microbiol., 2014, 14(1), 74.
[22]
Varano, M.; Gaspari, M.; Quirino, A.; Cuda, G.; Liberto, M.C.; Focà, A. Temperature‐dependent regulation of the Ochrobactrum anthropi proteome. Proteomics, 2016, 16(23), 3019-3024.
[23]
Daxboeck, F.; Zitta, S.; Assadian, O.; Krause, R.; Wenisch, C.; Kovarik, J. Ochrobactrum anthropi bloodstream infection complicating hemodialysis. Am. J. Kidney Dis., 2002, 40(4)e17
[24]
Gill, M.V.; Ly, H.; Mueenuddin, M.; Schoch, P.E.; Cunha, B.A. Intravenous line infection due to Ochrobactrum anthropi (CDC group Vd) in a normal host. Heart Lung, 1997, 26(4), 335-336.
[25]
Miller, D.L.; O’Grady, N.P. Guidelines for the prevention of intravascular catheter-related infections: Recommendations relevant to interventional radiology for venous catheter placement and maintenance. J. Vasc. Interv. Radiol., 2012, 23(8), 997-1007.
[26]
Gahlot, R.; Nigam, C.; Kumar, V.; Yadav, G.; Anupurba, S. Catheter-related bloodstream infections. Int. J. Crit. Illn. Inj. Sci., 2014, 4(2), 162-167.
[27]
Bell, T.; O’Grady, N.P. Prevention of central line–associated bloodstream infections. Infect. Dis. Clin., 2017, 31(3), 551-559.
[28]
Mermel, L.A. Correction: Catheter related bloodstream-infections. Ann. Intern. Med., 2000, 133(5), 395.
[29]
Thom, K.A.; Kleinberg, M.; Roghmann, M.C. Infection prevention in the cancer center. Clin. Infect. Dis., 2013, 57(4), 579-585.
[30]
Friedman, N.D.; Kaye, K.S.; Stout, J.E.; McGarry, S.A.; Trivette, S.L.; Briggs, J.P.; Lamm, W.; Clark, C.; MacFarquhar, J.; Walton, A.L.; Reller, L.B.; Sexton, D.J. Health care-associated bloodstream infections in adults: A reason to change the accepted definition of community-acquired infections. Ann. Intern. Med., 2002, 137(10), 791-797.
[31]
Al-Tawfiq, J.A.; Tambyah, P.A. Healthcare associated infections (HAI) perspectives. J. Infect. Public Health, 2014, 7(4), 339-344.
[32]
Kettaneh, A.; Weill, F.X.; Poilane, I.; Fain, O.; Thomas, M.; Herrmann, J.L.; Hocqueloux, L. Septic shock caused by Ochrobactrum anthropi in an Otherwise Healthy Host. J. Clin. Microbiol., 2003, 41(3), 1339-1341.
[33]
Wu, A.W.; Lipshutz, A.K.; Pronovost, P.J. Effectiveness and efficiency of root cause analysis in medicine. JAMA, 2008, 299(6), 685-687.
[34]
Safdar, N.; Kluger, D.M.; Maki, D.G. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: Implications for preventive strategies. Medicine , 2002, 81(6), 466-479.
[35]
Dang, V.M.; Francois, P.; Batailler, P.; Seigneurin, A.; Vittoz, J.P.; Sellier, E.; Labarère, J. Medical record-keeping and patient perception of hospital care quality. Int. J. Health Care Qual. Assur., 2014, 27(6), 531-543.
[36]
Pomara, C.; D’Errico, S.; Neri, M.; Riezzo, I.; Telesforo, F.; Martelloni, M. Quality of the medical record as a medical - legal indicator of appropriateness and instrument for clinical risk management. First Pugliese experience in private healthcare - verification and analysis of the results of a study on 2000 medical records. Profession - Culture Prac. Doctor D’Oggi, 2009, 8, 24-30.
[37]
Pronovost, P.; Needham, D.; Berenholtz, S.; Sinopoli, D.; Chu, H.; Cosgrove, S.; Sexton, B.; Hyzy, R.; Welsh, R.; Roth, G.; Bander, J.; Kepros, J.; Goeschel, C. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med., 2006, 355(26), 2725-2732.
[38]
O’grady, N.P.; Alexander, M.; Burns, L.A.; Dellinger, E.P.; Garland, J.; Heard, S.O.; Masur, H.; Mermel, L.A.; Pearson, M.L.; Raad, I.I.; Randolph, A.G.; Rupp, M.E.; Saint, S. Guidelines for the prevention of intravascular catheter-related infections. Clin. Infect. Dis., 2011, 52(9), e162-e193.
[39]
Allegranzi, B.; Nejad, S.B.; Combescure, C.; Graafmans, W.; Attar, H.; Donaldson, L.; Pittet, D. Burden of endemic health-care-associated infection in developing countries: Systematic review and meta-analysis. Lancet, 2011, 377(9761), 228-241.
[40]
Maki, D.G.; Stolz, S.M.; Wheeler, S.; Mermel, L.A. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann. Intern. Med., 1997, 127(4), 257-266.
47
12
1
1